Skip to main content
Erschienen in: Rheumatology International 5/2008

01.03.2008 | Original Article

Differential expression of toll-like receptor 6 on granulocytes and monocytes implicates the role of microorganisms in Behcet’s disease etiopathogenesis

verfasst von: Sule Yavuz, Yesim Elbir, Aysin Tulunay, Emel Eksioglu-Demiralp, Haner Direskeneli

Erschienen in: Rheumatology International | Ausgabe 5/2008

Einloggen, um Zugang zu erhalten

Abstract

The objective of this study was to investigate the expressions of toll-like receptors on neutrophils and monocytes in Behcet’s disease (BD). Forty-two patients with BD were included in the study. Baseline and stimulated cells with heat shock protein-60 (HSP-60), lipopolysaccharide (LPS) and crude extract of Streptococcus sanguis (SS) were analyzed for toll-like receptor-1, -2, -4 and -6 expressions using flow cytometer. Results were confirmed using semi-quantitative PCR technique. The mean frequency of TLR-6 expressing granulocytes in BD patients was significantly lower than in controls (4.2 ± 0.6 vs. 9.2 ± 0.6 and 8.0 ± 1.4, BD vs. rheumatoid arthritis (RA) and healthy control (HC); P < 0.05). TLR-6 expressing granulocyte population was enhanced after stimulation with HSP-60 and SS (20 ± 0.5 and 12.8 ± 0.6, respectively). Decreased TLR-2 expression was noted in monocytes of BD patients after stimulation with HSP-60 and LPS (71.0 ± 0.5 and 73.0 ± 0.5; P < 0.02, for both antigens). Functional abnormalities of these receptors or different activation cascades by different microorganisms are associated with disease pathogenesis in Behcet’s disease.
Literatur
1.
Zurück zum Zitat Yazici H, Yurdakul S, Hamuryudan V (1998) Behcet’s syndrome. In: Klippel JH, Dieppe PA (eds) Rheumatology. Mosby, London, 7:26:1–6 Yazici H, Yurdakul S, Hamuryudan V (1998) Behcet’s syndrome. In: Klippel JH, Dieppe PA (eds) Rheumatology. Mosby, London, 7:26:1–6
2.
Zurück zum Zitat Mumcu G, Inanc N, Yavuz S, Direskeneli H (2007). The role of infectious agents in the pathogenesis, clinical manifestations and treatment strategies in Behcet’s disease. Clin Exp Rheumatol, Sept. 2007 Supplement Mumcu G, Inanc N, Yavuz S, Direskeneli H (2007). The role of infectious agents in the pathogenesis, clinical manifestations and treatment strategies in Behcet’s disease. Clin Exp Rheumatol, Sept. 2007 Supplement
3.
Zurück zum Zitat Lehner T, Lavery E, Smith R et al (1991) Association between the 65 kDa heat shock protein, Streptoccocus sanguis and the corresponding antibodies in Behcet’s syndrome. Infect Immun 59:1434–1441PubMed Lehner T, Lavery E, Smith R et al (1991) Association between the 65 kDa heat shock protein, Streptoccocus sanguis and the corresponding antibodies in Behcet’s syndrome. Infect Immun 59:1434–1441PubMed
4.
Zurück zum Zitat Mumcu G, Ergun T, Inanc N et al (2004) Oral health is impaired in Behcet’s disease and associated with disease severity. Rheumatology 43:1028–1033PubMedCrossRef Mumcu G, Ergun T, Inanc N et al (2004) Oral health is impaired in Behcet’s disease and associated with disease severity. Rheumatology 43:1028–1033PubMedCrossRef
5.
Zurück zum Zitat Direskeneli H, Eksioglu-Demiralp E, Yavuz S, Ergun T, Lehner T, Akoglu T (2000) T cell responses to 60/65 kDa HSP derived peptides in Turkish Behcet’s disease patients. J Rheum 27:708–713PubMed Direskeneli H, Eksioglu-Demiralp E, Yavuz S, Ergun T, Lehner T, Akoglu T (2000) T cell responses to 60/65 kDa HSP derived peptides in Turkish Behcet’s disease patients. J Rheum 27:708–713PubMed
6.
Zurück zum Zitat Miura T, Ishihara K, Kato T et al (2005) Detection of heat shock proteins but not superantigen by isolated oral bacteria from patients with Behcet’s disease. Oral Microbial Immunol 20:167–171CrossRef Miura T, Ishihara K, Kato T et al (2005) Detection of heat shock proteins but not superantigen by isolated oral bacteria from patients with Behcet’s disease. Oral Microbial Immunol 20:167–171CrossRef
7.
Zurück zum Zitat Kol A, Lichtman AH, Finberg RW, Libby P, Kurt-Jones EA (2000) Heat shock protein 60 activates the innate immune response: CD14 is an essential receptor for HSP-60 activation of mononuclear cells. J Immunol 164:13–17PubMed Kol A, Lichtman AH, Finberg RW, Libby P, Kurt-Jones EA (2000) Heat shock protein 60 activates the innate immune response: CD14 is an essential receptor for HSP-60 activation of mononuclear cells. J Immunol 164:13–17PubMed
8.
Zurück zum Zitat Chen W, Syldath U, Bellman K, Burkart V, Kolb H (1999) Human 60-kDa Heat shock protein: a danger signal to the innate immune system. J Immunol 162:3212–3219PubMed Chen W, Syldath U, Bellman K, Burkart V, Kolb H (1999) Human 60-kDa Heat shock protein: a danger signal to the innate immune system. J Immunol 162:3212–3219PubMed
9.
10.
Zurück zum Zitat Henneke P, Morath S, Uematsu S et al (2005) Role of lipoteichoic acid in the phagocyte response to group B streptococcus. J Immunol 174:6449–6455PubMed Henneke P, Morath S, Uematsu S et al (2005) Role of lipoteichoic acid in the phagocyte response to group B streptococcus. J Immunol 174:6449–6455PubMed
11.
Zurück zum Zitat Takeuchi O, Kawai T, Muhiracht PF et al (2001) Discrimination of bacterial lipoproteins by toll-like receptor 6. Int Immunol 13:933–940PubMedCrossRef Takeuchi O, Kawai T, Muhiracht PF et al (2001) Discrimination of bacterial lipoproteins by toll-like receptor 6. Int Immunol 13:933–940PubMedCrossRef
12.
Zurück zum Zitat International study group for Behcet’s disease (1990) Criteria for diagnosis of Behcet’s disease. Lancet 335:1078–1080 International study group for Behcet’s disease (1990) Criteria for diagnosis of Behcet’s disease. Lancet 335:1078–1080
13.
Zurück zum Zitat Nakao Y, Funami K, Kikkawa S et al (2005) Surface-expressed TLR-6 participates in the recognition of diacylated lipopeptide and peptidolgycan in human cells. J Immunol 174:1566–1573PubMed Nakao Y, Funami K, Kikkawa S et al (2005) Surface-expressed TLR-6 participates in the recognition of diacylated lipopeptide and peptidolgycan in human cells. J Immunol 174:1566–1573PubMed
14.
Zurück zum Zitat Omueti KO, Beyer JM, Johnson CN, Lyle EA, Tapping RI (2005) Domain exchange between human toll-like receptors 1and 6 reveals a region required for lipopeptide discrimination. J Biol Chem 280:36616–36625PubMedCrossRef Omueti KO, Beyer JM, Johnson CN, Lyle EA, Tapping RI (2005) Domain exchange between human toll-like receptors 1and 6 reveals a region required for lipopeptide discrimination. J Biol Chem 280:36616–36625PubMedCrossRef
15.
Zurück zum Zitat Iwahashi M, Yamamura M, Aita T et al (2004) Expression of toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis. Arthritis Rheum 50:1457–1467PubMedCrossRef Iwahashi M, Yamamura M, Aita T et al (2004) Expression of toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis. Arthritis Rheum 50:1457–1467PubMedCrossRef
16.
Zurück zum Zitat Kawanaka N, Yamamura M, Aita T et al (2002) CD14 + CD16 + blood monocytes and joint inflammation in rheumatoid arthritis. Arthritis Rheum 46:2578–2586PubMedCrossRef Kawanaka N, Yamamura M, Aita T et al (2002) CD14 + CD16 + blood monocytes and joint inflammation in rheumatoid arthritis. Arthritis Rheum 46:2578–2586PubMedCrossRef
17.
Zurück zum Zitat Belge KU, Dayyani F, Horelt A et al (2002) The proinflammatory CD14 + CD16 + DR++ monocytes are a major source of TNF. J Immunol 168:3536–3542PubMed Belge KU, Dayyani F, Horelt A et al (2002) The proinflammatory CD14 + CD16 + DR++ monocytes are a major source of TNF. J Immunol 168:3536–3542PubMed
18.
Zurück zum Zitat Sahin S, Lawrence R, Direskeneli H, Hamuryudan V, Yazici H, Akoglu T (1996) Monocyte activity in Behcet’s disease. Br J Rheum 35:424–429CrossRef Sahin S, Lawrence R, Direskeneli H, Hamuryudan V, Yazici H, Akoglu T (1996) Monocyte activity in Behcet’s disease. Br J Rheum 35:424–429CrossRef
Metadaten
Titel
Differential expression of toll-like receptor 6 on granulocytes and monocytes implicates the role of microorganisms in Behcet’s disease etiopathogenesis
verfasst von
Sule Yavuz
Yesim Elbir
Aysin Tulunay
Emel Eksioglu-Demiralp
Haner Direskeneli
Publikationsdatum
01.03.2008
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 5/2008
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-007-0470-y

Weitere Artikel der Ausgabe 5/2008

Rheumatology International 5/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.